glp-1 receptor agonists and cancer risk in adults with obesity GLP-1s may reduce related risk, new research shows. Across large observational cohorts, they were linked to reduced rates of endometrial, liver, colorectal, other cancers. Learn more at the link Glucagon-like peptide 1 receptor agonists
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

.png?w=1536&max-h=2752&fit=crop&auto=format)

)




















